Chapter 4

Palliative Care, Hospice Care, Advance Care Planning, and Advance Directives

A. Taylor,    Brigham and Women’s Dana-Farber Cancer Center, Boston, MA, United States

Abstract

This chapter discusses palliative care, hospice care, and advance care planning (ACP) and advance directives (ADs) in the oncology setting. The background and definitions are outlined for each of these three topics. The palliative care and hospice sections then go on to discuss guidelines for their respective disciplines followed by a description of the services provided, the setting(s) they are provided in, barriers to enrollment and evidence-based outcomes. The ACP and ADs section outlines the utilization of such planning at the end of life by patients with advanced cancer, the effectiveness of ACP and ADs, and the required documents. Resources are provided at the conclusion of each of the three discussion topics.

Keywords

Palliative care; hospice care; advance care planning; advance directive; oncology; cancer; radiation oncology; end of life; serious illness; POLST; MOLST; DNR

You matter because of who you are. You matter to the last moment of your life, and we will do all we can, not only to help you die peacefully, but also to live until you die.

Dame Cicely Saunders

Background

Hospice care was first recognized as a medical specialty in the 1940s in England. Dame Cicely Saunders worked with the terminally ill and went on to create St. Christopher’s Hospice. It was not until the 1960s that this specialty started to take hold in the United States and in 1982 the Medicare hospice benefit was created within the Tax Equity and Fiscal Responsibility Act. In order to qualify for the Medicare hospice benefit a provider must certify that, to the best of their judgment, a patient’s life expectancy is 6 months or less.

It was not until the early 1970s that the term “palliative care” was used by Balfour Mount to describe his new program at the Royal Victoria Hospital in Montreal, modeled on St. Christopher’s Hospice [1]. Although hospice care and palliative care programs share commonalities in the type of services provided, they differ in where they are utilized along the treatment trajectory. Hospice focuses on comfort rather than curative measures in the terminal phase of illness, while palliative care focuses on pain and symptom relief at any phase of a serious illness.

image

Palliative Care

Definitions

The following definitions reflect the modern concept of palliative care:

• The World Health Organization (WHO) defines palliative care as: “An approach that improves the quality of life (QOL) of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial, and spiritual” [2].

• The Centers for Medicare and Medicaid Services (CMS) have endorsed the following definition: “Palliative care means patient and family-centered care that optimizes QOL by anticipating, preventing, and treating suffering. Palliative care throughout the continuum of illness involves addressing physical, intellectual, emotional, social, and spiritual needs and facilitating patient autonomy, access to information, and choice” [3].

• The Center to Advance Palliative Care defines palliative care as: “Specialized medical care for people with serious illnesses … focused on providing patients with relief from the symptoms, pain and stress of a serious illness—whatever the diagnosis. The goal is to improve QOL for both the patient and the family. Palliative care is provided by a team of doctors, nurses, and other specialists who work together with a patient’s other doctors to provide an extra layer of support. It is appropriate at any age and at any stage in a serious illness and can be provided along with curative treatment” [4].

Guidelines

• The American Society for Radiation Oncology (ASTRO) has established three palliative guidelines [5]:

ent Palliative radiotherapy for bone metastases (2011).

ent Palliative thoracic radiotherapy in lung cancer (2011).

ent Radiotherapeutic and surgical management for newly diagnosed brain metastasis (2012).

• In 2012, the American Society of Clinical Oncology (ASCO), published a provisional clinical opinion (PCO) based on seven published randomized controlled trials (RCTs) that combined standard oncology care and palliative care should be considered early in the course of illness for any patient with metastatic cancer and/or high symptom burden [6].

• The National Consensus Project for Quality Palliative Care published the third edition of their guidelines in 2013. These guidelines “promote quality palliative care, foster consistent and high standards in palliative care, and encourage continuity of care across settings.” There are eight domains of care: 1: Structure and Processes of Care; 2: Physical Aspects of Care; 3: Psychological and Psychiatric Aspects; 4: Social Aspects of Care; 5: Spiritual, Religious, and Existential Aspects of Care; 6: Cultural Aspects of Care; 7: Care of the Patient at the End of Life (EOL); and 8: Ethical and Legal [7].

Palliative Care Services

• Symptom management.

• Establishing goals of care that are in keeping with the patient’s values and preferences

ent Code status.

ent Advance directives.

• Consistent and sustained communication between the patient and all those involved in his or her care.

• Psychosocial, spiritual, and practical support both to patients and their family caregivers.

• Coordination across sites of care.

Interdisciplinary Team

• Physicians.

• NPs/PAs.

• Registered nurses.

• Social workers.

• Spiritual Counselor.

• Pharmacists.

Setting

• Hospital

ent Consultative service.

ent Inpatient palliative care units.

ent Comanagement models.

• Ambulatory setting.

• Nursing home.

• Home.

• Hospice.

Barriers

• Key barriers to palliative care integration across three WHO domains:

ent Education domain: Lack of adequate education/training and perception of palliative care as end-of-life care.

ent Implementation domain: Inadequate size of palliative medicine-trained workforce, challenge of identifying patients appropriate for palliative care referral, and need for culture change across settings.

ent Policy domain: Fragmented health care system, need for greater funding for research, lack of adequate reimbursement for palliative care, and regulatory barriers [8].

Outcomes

• A metaanalysis of 19 studies concluded that palliative care and hospice teams improved patients’ pain and other symptoms [9].

• In a landmark study, patients with newly diagnosed metastatic nonsmall cell lung cancer who were randomly assigned to early palliative care integrated with standard oncologic care had a better QOL, less depressive symptoms, and longer median survival than did those who were assigned to oncologic care alone [10].

ent The ambulatory palliative care assessment in this trial focused on symptom management, patient, and family coping, and illness understanding and education [11].

ent In a later analysis, patients receiving early palliative care received the same number of chemotherapy regimens as did those in the control group but they were less likely to have chemotherapy continued close to death and more likely to enroll in hospice for a longer duration [12].

• The ENABLE II trial demonstrated higher scores for QOL and mood in patients with any life-limiting cancer (prognosis of approximately 1 year) who received psychoeducational palliative intervention in addition to standard care [13].

• The ENABLE III trial randomly assigned patients with advanced cancer to receive an in-person palliative care consult, structured palliative care telehealth nurse coaching sessions (once per week for six sessions), and monthly follow-up either early after enrollment or 3 months later.

ent Outcomes were QOL, symptom impact, mood, 1-year survival, and resource use (hospital/intensive care unit days, emergency room visits, chemotherapy in last 14 days, and death location).

ent Early-entry participants’ patient-reported outcomes and resource use were not statistically different; however, their survival 1-year after enrollment was improved compared with those who began 3 months later [14].

• A randomized trial demonstrated that comprehensive outpatient palliative care in patients who continue to pursue disease modifying treatment, compared to usual care, improves symptom management, and patient satisfaction [15,16].

• Many clinicians fear that conversations about EOL issues with have a negative impact on patient’s QOL, however, this has not panned out it the literature. Failure to have these conversations has documented adverse effects [1721]:

ent Care inconsistent with values and goals.

ent Inferior QOL.

ent Prolonged death and increased suffering.

ent Inferior bereavement outcomes.

ent Increased costs without benefits.

• Palliative care with a strong emphasis on quality communication is a high-value intervention and results in [10,11,13,2225]:

ent Better QOL.

ent Reduction in the use of aggressive care.

ent Lower cost.

ent 25% increase in survival [10].

Unfortunately, we do not have enough palliative care clinicians to reach all patients who would benefit from such specialized care. To bridge this gap, Dr. Susan Block created a tool to provide a systematic approach for nonpalliative care clinicians. The tool is called the Serious Illness Conversation Guide and with her permission is included in the below table.

image
© 2015, Ariadne Labs: A Joint Center for Health Systems Innovation (www.ariadnelabs.org) and Dana-Farber Cancer Institute. Licensed Under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, http://creativecommons.org/licenses/by-nc-sa/4.0/

Hospice

Eligibility: Medical guidelines for determining appropriateness of hospice referral: Documenting decline. Obtained from the Centers for Medicare and Medicaid Services.

A patient will be considered to have a life expectancy of 6 months or less if he/she meets the following criteria for decline in clinical status, when they are not considered to be reversible:

1. Progression of disease as documented by worsening clinical status, symptoms, signs, and laboratory results

a. Clinical status

i. Recurrent or intractable infections such as pneumonia, sepsis, or upper urinary tract infection.

ii. Progressive inanition as documented by weight loss not due to reversible causes (depression, diuretics), decreasing anthropomorphic measurements (mid-arm circumference, abdominal girth), not due to reversible causes (depression, diuretics), decreasing serum albumin, or cholesterol, dysphagia leading to recurrent aspiration and/or inadequate oral intake documented by decreased food portion consumption.

b. Symptoms

i. Dyspnea with increased respiratory rate.

ii. Cough, intractable.

iii. Nausea/vomiting poorly responsive to treatment.

iv. Diarrhea, intractable

v. Pain, requiring increasing doses of analgesia.

c. Signs

i. Decline in systolic blood pressure below 90 or progressive postural hypotension.

ii. Ascites.

iii. Venous, arterial, or lymphatic obstruction due to local progression or metastatic disease.

iv. Edema.

v. Pleural/pericardial effusion.

vi. Weakness.

vii. Change in level of consciousness.

d. Laboratory (when available, lab testing not required to establish hospice eligibility)

i. Increasing PaCO2 or decreasing PaO2, or decreased SaO2.

ii. Increasing calcium, creatinine, liver function.

iii. Increasing tumor markers (CEA, PSA).

iv. Progressively decreasing or increasing sodium or increasing serum potassium.

2. Decline in Karnofsky Performance Status (KPS) or Palliative Performance Status from <70%, due to progression of disease.

3. Increasing emergency room visits, hospitalizations, or physicians’ visits related to hospice primary diagnosis.

4. Progressive decline in Functional Assessment Staging (FAST) for dementia (from ≥7A on the FAST).

5. Progression to dependence on assistance with additional activities of daily living.

6. Progressive stage 3–4 pressure ulcers despite optimal care.

Image

PaO2, arterial oxygen tension; PaCO2, arterial carbon dioxide tension; SaO2, arterial oxyhemoglobin saturation; CEA, carcinoembryonic antigen; PSA, prostate-specific antigen.

Source: Centers for Medicare & Medicaid Services. Local Coverage Determination (LCD) for Hospice Determining Terminal Status (L32015) [accessed 28.08.2015].

Medical guidelines for determining appropriateness of hospice referral: Nondisease specific baseline guidelines plus comorbidities.

A patient will be considered to have a life expectancy of 6 months and be eligible for hospice services if he/she meets criteria for BOTH the following nondisease specific baseline guidelines AND disease-specific guidelines (shown on a separate table)
Both A and B should be met:

1. Physiologic impairment of functional status as demonstrated by Karnofsky Performance Status (KPS) or Palliative Performance Score (PPS) <70%. Note that two of the disease-specific guidelines (HIV and stroke/coma) establish a lower qualifying KPS or PPS.

2. Dependence on assistance for two or more activities of daily living (ADLs)

a. Feeding.

b. Ambulation.

c. Continence.

d. Transfer.

e. Bathing.

f. Dressing.

Comorbidities
Although not the primary hospice diagnosis, the presence of comorbid disease which is likely to contribute to a life expectancy of 6 months or less should be considered for hospice eligibility. Comorbid diseases may include:

1. Chronic obstructive pulmonary disease.

2. Congestive heart failure.

3. Ischemic heart disease.

4. Diabetes mellitus.

5. Neurologic disease (CVA, ALS, MS, Parkinson).

6. Renal failure.

7. Liver disease.

8. Neoplasia.

9. Acquired immune deficiency syndrome.

10. Dementia.

Image

CVA, cerebrovascular accident or stroke; ALS, amyotrophic lateral sclerosis; MS, multiple sclerosis.

Source: Centers for Medicare & Medicaid Services. Local Coverage Determination (LCD) for Hospice Determining Terminal Status (L32015) [accessed 28.08.2015].

Criteria for Enrollment in the Medicare Hospice Benefit

1. Eligibility for Medicare part A, which is the benefit that covers hospice in addition to other care services (i.e., inpatient hospitalization, skilled nursing facility care, nursing home care, and home health services).

2. Medicare-approved hospice.

3. A statement signed by the patient indicating that they are choosing hospice care instead of regular Medicare. Of note, Medicare regulations allow for regular Medicare reimbursement for incidental medical expenses that are unrelated to the terminal illness (e.g., acute myocardial infarction in a patient with advanced cancer).

4. Certification by both the patient’s personal physician and the hospice medical director that the patient has a terminal illness and is likely to have less than 6 months to live if the disease follows its usual course. In addition, the patient’s treatment goals should emphasize alleviating symptoms of illness and focusing on comfort and QOL rather than cure of the underlying disease.

Hospice Services

Once enrolled in the Medicare hospice benefit (MHB), all care related to their terminal illness must be covered by their hospice at an average hospice per diem reimbursement of $150 per day. As a result, many treatments may be cost prohibitive [26].

• Skilled nursing care.

• Symptom management.

• Psychosocial and spiritual care.

• Short-term inpatient care for difficult to control symptoms.

• Short-term respite is available for 5 days for every 30 days when caregivers are overwhelmed at home.

• Provides medications related to terminal condition, medical supplies and equipment.

• Bereavement care to surviving family and caregivers.

Interdisciplinary Care Team

• The patient’s personal physician (typically the primary care physician or medical oncologist).

• Hospice physician (or medical director).

• NPs/PAs.

• Registered nurses.

• Home health aides.

• Social workers.

• Clergy or other counselors.

• Trained volunteers.

• Speech, physical, and occupational therapists, if needed.

Setting [27]

• Home

ent The majority of people receiving hospice get their care at home in a private residence. However, hospice care can also take place in residential facilities, assisted living, or nursing homes. A main caregiver is identified as the individual responsible for around-the-clock supervision of the patient. This person is with the patient most of the time and is trained to provide much of the hands-on care.

• Nursing home

ent Many nursing homes and other long-term care facilities have small hospice units. Some have staff trained to care for hospice patients while others contract with outside hospice agencies to provide care. This can be a good option for patients who want hospice care but do not have primary caregivers to take care of them at home.

• Residential hospice

ent Many communities have free-standing, independently owned hospices that feature inpatient care buildings as well as home care hospice services. A free-standing hospice can benefit patients who do not have a caregiver at home or those that do not want to die in their residence which comes up frequently with parents with young children.

• Inpatient setting

ent Hospitals may have a dedicated hospice program and/or a special hospice unit that they staff. Others consult outside hospice teams that visit patients, provide recommendations, patient support, and staff education/support.

ent To find a hospice in your area:

ent http://www.nhpco.org/find-hospice

ent http://www.hospicedirectory.org/

ent http://www.cancer.org/treatment/findingandpayingfortreatment/choosingyourtreatmentteam/hospicecare/hospice-care-how-to-find

Reasons for Discharge [28]

• Medical condition stabilizes (79%).

• Patient or family decision (12%).

• Decision is made to pursue more aggressive therapy (7%).

Barriers to Enrollment

• The first national survey of the enrollment policies of 591 hospices showed [26]:

ent 78% of hospice programs reported having at least one policy that could restrict access.

ent 61% of hospices won’t accept a patient on chemotherapy.

ent 55% of hospices won’t accept someone relying on parenteral nutrition.

ent 40% of hospices won’t accept patients requiring transfusions.

ent 30% of hospices won’t accept a patient who needs radiation therapy.

ent 32% of hospices won’t accept a patient with an intrathecal catheter.

ent 30% of hospices require a caregiver at home.

ent 12% of hospices won’t accept patients with tube feedings.

ent Only 30% of hospices offer some form of open access enrollment. This is possible for patients who are not yet eligible for hospice under the MHB. These patients have the traditional hospice services while simultaneously retaining access to medical treatments such as palliative chemotherapy, radiation, and transfusions.

• Smaller hospices (average daily census of 60), for-profit hospices, and hospices in certain regions of the country consistently reported more limited enrollment policies.

• Larger hospices (average daily census of 200) were more likely to have no restrictive enrollment policies or open access enrollment [26].

• The average hospice stay is 2 weeks with average daily Medicare reimbursement rate of $150 per day.

ent The highest costs to the hospice are around admission (equipment, staff visits, medications, durable medical equipment) and death (staff visits, medications, etc.).

ent Per Meyers et al. [29]:

– For 6 month hospice stay the hospice would be reimbursed $27,000.

– For a 2 week hospice stay the amount decreases to $2100.

– Palliative radiation costs can be as much as $10,000 and out of reach for many small hospices across the country.

ent Hospice and palliative radiation are not mutually exclusive; if an individual hospice organization is able to absorb the cost of radiation it would be an available treatment option.

Outcomes

• A secondary Analysis of The National Hospice Study revealed an improved quality of death in patients receiving hospice care [30].

• In a mortality follow-back survey, family members of patients who died in hospice were significantly more satisfied with the care than those of patients who died while receiving care in hospitals, nursing homes, or home health agencies [31].

• Family survivors are less likely to experience posttraumatic stress disorder and prolonged grief disorder after hospice care as compared to those whose loved ones died in a hospital or intensive care unit [32].

• Increasing evidence also suggests that hospice is associated with decreased direct (billed services) costs in the home setting, particularly for patients with cancer [33,34]. In contrast, data on the consequences of increased access to, and length of stay in, hospice among nursing home residents suggest that despite reduced hospital utilization, total Medicare spending is actually higher for hospice beneficiaries in nursing homes, by an average of around $6000 per person [35].

• Finally, the available data suggest that 80% of Americans prefer to die at home but that only approximately 25% do [36]. However, among the patients who die with hospice involved in their care, 75% die at home.

Resources

Advance Care Planning and Advance Directives

Definitions

Advance care planning

Advance care planning (ACP) involves an ongoing discussion between patients, their families and health care professionals regarding goals, values, and beliefs. Exploration of these topics allows the patient to discover what is important to them and their family members regarding current and future medical care. The process of ACP informs and empowers patients to have a say about their current and future treatment [37].

Advance Directives

Advance directives (ADs) are the documents utilized to record treatment preferences. These documents vary depending on geographic location and include: Durable power of attorney for health care (health care proxy); living will and medical orders, such as do not resuscitate (DNR); and physician orders for life-sustaining treatment/medical orders for life-sustaining treatment (POLST/MOLST).

Utilization

• Planning for the EOL often occurs late or not at all. Several studies have shown that patients with serious medical illnesses do not discuss EOL preferences, or that the first discussions occur in the last days to months of life [1719].

• For patients with advanced cancer [20]:

ent The first EOL discussion occurred median 33 days prior to death.

ent 55% of initial EOL discussions occurred in the hospital.

ent Only 25% of these discussions were conducted by the patient’s oncologist.

ent Misconceptions held by health care providers that were disproved:

– It will make people depressed—Incorrect.

– It will take away hope—Incorrect.

– Involvement of Hospice or Palliative care will Reduce Survival—Incorrect.

– We do not really know a patient’s prognosis—True, but with qualifications.

– Talking about prognosis is not culturally appropriate—Incorrect.

– We do not like to have these discussions, and they are hard on us—True.

**Why It Matters**

• Patients lose good time with their families and for reflection and spend more time in the hospital and intensive care units.

• Patients and families want prognostic information, and it supports their ability to make decisions that are right for them.

• Several guidelines recommended by these authors about disclosing a poor prognosis:

ent Back AL, Arnold RM. Discussing prognosis: “How much do you want to know?”—Talking to patients who do not want information or who are ambivalent. J Clin Oncol 2006;24:4214–4217 [38].

ent Back AL, Arnold RM. Discussing prognosis: “How much do you want to know?”—Talking to patients who are prepared for explicit information. J Clin Oncol 2006;24:4209–4213 [39].

ent Back AL, Arnold RM, Tulsky JA. Mastering communication with seriously ill patients: balancing honesty with empathy and hope. Cambridge, United Kingdom, Cambridge University Press, 2009 [40].

• Minorities tend to have lower rates of ACP [41] and AD completion [42,43], with evidence that many AD documents as they currently exist are not culturally acceptable to them [42,44,45].

• Patient characteristics associated with a higher likelihood of completing an AD include [42,43,4648]:

ent Older age.

ent Caucasian race.

ent History of a chronic disease, including AIDS and cancer.

ent High disease burden.

ent Higher socioeconomic status.

ent Prior knowledge about AD and EOL care options.

ent Higher level of education.

• When ADs are discussed the discussions are often inadequate [37]:

ent Many conversations focus on medical procedures only and fail to address key elements of quality discussions:

– Prognosis.

– Tradeoffs.

– Unacceptable states.

– Treatment outcomes.

Effectiveness

• A systematic review of the impact of ADs was performed in 2014 [49]. The results were notable for:

ent Decreased rate of hospitalization and the chances of dying in the hospital in two out of five studies.

ent Decreased use of life-sustaining treatment in 10 out of 22 studies.

ent Increased use of hospice or palliative care in five out of seven studies.

• Earlier conversations addressing EOL discussions about patients goals and priorities and coordinated ACP [17,37,50]:

ent Improves EOL care and enhances goal-concordant care.

ent Reduces the incidence of anxiety, depression, and posttraumatic stress in surviving relatives thus improves bereavement outcomes.

ent Reduces burden of decision-making for families.

ent Improves patient and family satisfaction with hospital care.

ent Are associated with less aggressive medical care near death, fewer hospitalizations, and earlier hospice referrals.

Documents

• Durable Power of Attorney for Health Care—A Durable Power of Attorney for Health Care (DPAHC, Health Care Proxy (HCP), or Health care Power of Attorney) is a signed legal document authorizing another person to make medical decisions on the patient’s behalf in the event the patient loses decisional capacity [51].

• Living Will—The Living Will (LW) is a document detailing a person’s preferences regarding their medical care in circumstances in which they are no longer able to express informed consent. Typically addresses resuscitation and life support but may also include preferences regarding tube feedings, implantable defibrillators, dialysis, etc.

• Combined Directives—ACP documents are being developed that include components of the LW along with a values history and instructional directive, while also designating a surrogate decision-maker. One example is the “Five Wishes,” which combines the LW with the DPAHC [52].

• Physician Orders for Life-Sustaining Treatment (POLST)—The POLST paradigm is an approach to EOL planning emphasizing: (1) ACP conversations between patients, health care professionals, and loved ones; (2) shared decision-making between a patient and his/her health care professional about the care the patient would like to receive at the end of his/her life; and (3) ensuring patient wishes are honored. As a result of these conversations, patient wishes may be documented in a POLST form, which translates the shared decisions into actionable medical orders. The POLST form assures patients that health care professionals will provide only the treatments that patients themselves wish to receive, and decreases the frequency of medical errors. It is meant to complement ADs, not replace them.

Resources

• State specific laws regarding LW’s; http://www.caringinfo.org/i4a/pages/index.cfm?pageid=3289

• http://www.polst.org/educational-resources/

• Table 2. Randomized Controlled Trials of Decision Tools for ACP in:

Austin C, Mohottige D, Sudore R, Smith A, Hanson L. Tools to promote shared decision making in serious illness: a systematic review. JAMA Intern Med 2015;175(7):1213–1221. DOI: 10.1001/jamainternmed.2015.1679 [53].

• Table 3. Randomized Controlled Trials of Decision Tools for Current Treatment:

Austin C, Mohottige D, Sudore R, Smith A, Hanson L. Tools to promote shared decision making in serious illness: a systematic review. JAMA Intern Med 2015;175(7):1213–1221. DOI: 10.1001/jamainternmed.2015.1679 [53].

References

1. Billings A. What is palliative care. J Palliat Med. 1998;1(1):73–81.

2. World Health Organization (WHO) definition of palliative care. Available online at <http://www.who.int/cancer/palliative/definition/en>; [accessed 07.01.2011].

3. Federal Register 2008—73 FR 32204, June 5, 2008.

4. Center to Advance Palliative Care (CAPC) definition of palliative care. <http://www.capc.org/building-a-hospital-based-palliative-care-program/case/definingpc>; [accessed 04.09.2012].

5. https://www.astro.org/Clinical-Practice/Guidelines/Palliation.aspx.

6. Smith TJ, Temin S, Alesi ER, et al. American society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30(8):880–887.

7. National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for Quality Palliative Care, 2nd ed.; 2013. <http://www.nationalconsensusproject.org/AboutGuidelines.asp>.

8. Aldridge MD, Hasselaar J, Garralda E, et al. Education, implementation, and policy barriers to greater integration of palliative care: a literature review. Palliat Med. 2015;29.

9. Manfredi PL, Morrison RS, Morris J, Goldhirsch SL, Carter JM, Meier DE. Palliative care consultations: how do they impact the care of hospitalized patients? J Pain Symptom Manage. 2000;20:166.

10. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733.

11. Jacobsen J, Jackson V, Dahlin C, et al. Components of early outpatient palliative care consultation in patients with metastatic nonsmall cell lung cancer. J Palliat Med. 2011;14:459.

12. Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012;30:394.

13. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302:741.

14. Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. JCO. 2015;33(13):1438–1445.

15. Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med. 2004;164:83.

16. Rabow MW, Schanche K, Petersen J, Dibble SL, McPhee SJ. Patient perceptions of an outpatient palliative care intervention: “It had been on my mind before, but I did not know how to start talking about death...”. J Pain Symptom Manage. 2003;26:1010.

17. Wright A, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665–1673.

18. Dow LA, Matsuyama RK, Ramakrishnan V, et al. Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. JCO. 2010;28(2):299–304.

19. Halpern NA, Pastores SM, Chou JF, Chawla S, Thaler HT. Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact. J Palliat Med. 2011;14(4):483–489.

20. Mack JW, Smith TJ. Reasons why physician’s do not have discussions about poor prognosis, why it matters, and what can be improved. JCO. 2012;30(22):1715–1717.

21. Bernacki RE, Block SD. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174(12):1994–2003.

22. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721–1730.

23. Higginson IJ, Evans CJ. What is the evidence the palliative care teams improve outcomes for cancer patients and their families. Cancer J. 2010;16(5):423–435.

24. Back AL, Arnold RM. “Yes it’s sad, but what should I do?”: moving from empathy to action in discussing goals of care. J Palliat Med. 2014;17(2):141–144.

25. Lupu D. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage. 2010;40(6):899–911.

26. Aldridge MD, Barry CL, Cherlin EJ, McCorkle R, Bradley EH. Hospices’ enrollment policies may contribute to underuse of hospice care in the United States. Health Aff. 2012;31(12):2690–2698.

27. http://www.cancer.org/treatment/findingandpayingfortreatment/choosingyourtreatmentteam/hospicecare/hospice-care-settings.

28. Kutner JS, Meyer SA, Beaty BL, Kassner CT, Nowels DE, Beehler C. Outcomes and characteristics of patients discharged alive from hospice. J Am Geriatr Soc. 2004;52:1337.

29. Meyers DS. Palliative radiation therapy for the hospice patient: nuances of care and reimbursement. J Oncol Prac. 2015;11(1):87–88.

30. Wallston KA, Burger C, Smith RA, Baugher RJ. Comparing the quality of death for hospice and non-hospice cancer patients. Med Care. 1988;26:177.

31. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88.

32. Wright AA, Keating NL, Balboni TA, Matulonis UA, Block SD, Prigerson HG. Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol. 2010;28:4457.

33. Obermeyer Z, Makar M, Abujaber S, Dominici F, Block SD, Cutler DM. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer. JAMA. 2014;312:1888.

34. Brumley R, Enguidanos S, Jamison P, et al. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc. 2007;55:993.

35. Gozalo P, Plotzke M, Mor V, Miller SC, Teno JM. Changes in Medicare costs with the growth of hospice care in nursing homes. N Engl J Med. 2015;372:1823.

36. http://www.nhpco.org/hospice-statistics-research-press-room/facts-hospice-and-palliative-care [accessed 15.01.2015].

37. Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:1345.

38. Back AL, Arnold RM. Discussing prognosis: “How much do you want to know?”—Talking to patients who do not want information or who are ambivalent. J Clin Oncol. 2006;24:4214–4217.

39. Back AL, Arnold RM. Discussing prognosis: “How much do you want to know?”—Talking to patients who are prepared for explicit information. J Clin Oncol. 2006;24:4209–4213.

40. Back AL, Arnold RM, Tulsky JA. Mastering communication with seriously ill patients: balancing honesty with empathy and hope Cambridge, United Kingdom: Cambridge University Press; 2009.

41. Johnstone MJ, Kanitsaki O. Ethics and advance care planning in a culturally diverse society. J Transcult Nurs. 2009;20:405.

42. Simon-Lorda P, Tamayo-Velázquez MI, Barrio-Cantalejo IM. Advance directives in Spain Perspectives from a medical bioethicist approach. Bioethics. 2008;22:346. Bullock K. The influence of culture on end-of-life decision making. J Soc Work End Life Palliat Care. 2011;7:83.

43. Kwak J, Haley WE. Current research findings on end-of-life decision making among racially or ethnically diverse groups. Gerontologist. 2005;45:634.

44. Hickman SE, Hammes BJ, Moss AH, Tolle SW. Hope for the future: achieving the original intent of advance directives. Hastings Cent Rep 2005; Spec No:S26.

45. Blackhall LJ, Frank G, Murphy ST, Michel V, Palmer JM, Azen SP. Ethnicity and attitudes towards life sustaining technology. Soc Sci Med. 1999;48:1779.

46. Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T. Association between advance directives and quality of end-of-life care: a national study. J Am Geriatr Soc. 2007;55:189.

47. Evans N, Bausewein C, Meñaca A, et al. A critical review of advance directives in Germany: attitudes, use and healthcare professionals' compliance. Patient Educ Couns. 2012;87:277.

48. Aw D, Hayhoe B, Smajdor A, Bowker LK, Conroy SP, Myint PK. Advance care planning and the older patient. QJM. 2012;105:225.

49. Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014;28:1000.

50. Mack JW, Weeks JC, Wright A, Block SD, Prigerson HG. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010;28(7):1203–1208.

51. Sabatino CP. The evolution of health care advance planning law and policy. Milbank Q. 2010;88:211.

52. Five Wishes; <http://www.agingwithdignity.org> [accessed 29.12.2012].

53. Austin AC, Mohottige D, Sudore RL, Smith AK, Hanson LC. Tools to promote shared decision making in serious illness a systematic review. JAMA Intern Med. 2015;175(7):1213–1221.

..................Content has been hidden....................

You can't read the all page of ebook, please click here login for view all page.
Reset